Zimmer Biomet Q1 net sales $1.889B (+3.2%); adj. EPS $1.94; reiterates FY guidance

ZIMMER BIOMET HOLDINGS, INC.

2024-Q1 EPS reported $0.84 revenue$1,889,200,000

Net sales $1.889B, up 3.2% reported and 4.4% constant currency; GAAP diluted EPS $0.84, adjusted $1.94.
Knees $788.1M (+3.4%), Hips $491.2M (-0.3%), S.E.T. $452.6M (+4.4%).
Reiterates FY2024 guidance: constant currency revenue growth 5-6%, adjusted EBITDA $8.00-$8.15 EPS.
FDA 510(k) clearance for ROSA Shoulder System (first robotic shoulder assist) and Z1 Femoral Hip Stem.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ZIMMER BIOMET HOLDINGS, INC. updated its full-year 2024 guidance (reaffirmed).

Period: full-year 2024
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

The Company is reiterating its current full-year 2024 financial guidance. Projected Year Ending December 31, 2024 2024 Reported Revenue Change 4.5% - 5.5% Foreign Currency Exchange Impact (0.5)% 2024 Constant Currency Revenue Change 5.0% - 6.0% Adjusted Diluted EPS (1) $8.00 - $8.15

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ZIMMER BIOMET HOLDINGS, INC. reported quarter ended March 31, 2024 results: revenue $1.889 billion, net income $172.4 million, EPS $0.84.

Period: quarter ended March 31, 2024
Revenue: $1.889 billion
Net income: $172.4 million
EPS: $0.84
Result: reported results

Exact text from the filing

The Company reported first quarter net sales of $1.889 billion, an increase of 3.2% over the prior year period, and an increase of 4.4% on a constant currency 1 basis. Net earnings for the first quarter were $172.4 million, or $399.7 million on an adjusted 1 basis. Diluted earnings per share were $0.84 for the first quarter, and adjusted 1 diluted earnings per share were $1.94.

View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

ZIMMER BIOMET HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0000950170-24-051551

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.